For pharmaceutical policies the “two fundamental terms are ‘safety’ and ‘preparation’, and on this ground the task of the institutions is to create the regulatory environment around the private pharmaceutical industry, committed to providing prevention and safety, market and, when necessary, financial support for investments in research and production. This has not always happened adequately, but the pandemic has been a shock for all countries that has led to a review of public policies “. This was stated by Giancarlo Giorgetti, Minister of Economic Development, opening the event ‘InnovaCtion, what is needed for ideas to become health, business, future’, promoted by GlaxoSmithKline (Gsk) at its headquarters in Verona, on the occasion of the 90th anniversary of presence in our country.
“Today we know – underlined the minister – that it is not just a matter of supporting an industry in extremely rapid global growth, and therefore with a direct economic impact on the growth of a country, but of helping to secure the health of a population and therefore to ensure the fundamental conditions for the development of the entire national economy “.
“The Italian Government and, in particular, the Ministry of Economic Development, on the specific mandate of President Draghi – added Giorgetti – have consequently adopted a new strategic approach to the development of the pharmaceutical industry in Italy precisely on the basis of the awareness that this industry it plays a fundamental role for the competitiveness of the entire Italian economic and social system and more generally for the competitiveness of the European economy “.
#Giorgetti #shock #pandemic #review #pharmaceutical #policies